CML and Sprycel

If you have been diagnosed with chronic myeloid leukemia (CML), Sprycel® (dasatinib) may help slow down the progression of your cancer. This prescription chemotherapy drug works to treat this specific type of leukemia by reducing the activity of a certain type of protein in the body that the cancer cells need to grow.
CML is a slowly progressing leukemia in which bone marrow stem cells (the early cells that form blood cells) develop into many abnormal granulocytes (a type of white blood cell). Some of these cells never become mature white blood cells (also called blasts). Over time, the granulocytes and blasts crowd out the red blood cells and platelets in the bone marrow.
(For more information on using this drug to treat CML, click Sprycel Uses. This article also lists other possible uses and talks about whether it is safe for use in children.)
5 Easy Tips to Manage Visitors During Cancer Treatment
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.